Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-12-15
|
pubmed:abstractText |
We investigated the effect of recombinant tumor necrosis factor-alpha (rTNF-alpha) on the proliferative response of human umbilical vein endothelial cells (HUVEC) to normal human serum (NHS), in the absence or the presence of interferon (IFN)-gamma. rTNF-alpha significantly impaired NHS-stimulated HUVEC growth at a dose as low as 0.1 U/ml. The inhibitory effect of rTNF-alpha was dose-dependent up to 50-100 U/ml and was already evident after 2 h of incubation. Doses of rTNF-alpha in the range of 10 U/ml completely suppressed 3H-thymidine uptake stimulated by 7.5% NHS, and the effect was partially overcome by 10-20% NHS. rTNF-alpha was not cytotoxic at doses up to 1000 U/ml. rIFN-gamma was also effective in suppressing NHS-stimulated 3H-thymidine incorporation, and at low doses (0.1 U/ml) rIFN-gamma and rTFN-alpha showed an additive effect. The effect of TFN-alpha and IFN-gamma in antagonizing the proliferative response of vascular endothelium to the variety of growth factors contained in human serum could be relevant in a variety of pathologic conditions involving endothelium damage and proliferation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0300-8916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
301-5
|
pubmed:dateRevised |
2008-12-12
|
pubmed:meshHeading |
pubmed-meshheading:7974803-Cell Division,
pubmed-meshheading:7974803-Dose-Response Relationship, Drug,
pubmed-meshheading:7974803-Endothelium, Vascular,
pubmed-meshheading:7974803-Humans,
pubmed-meshheading:7974803-Interferon-gamma,
pubmed-meshheading:7974803-Recombinant Proteins,
pubmed-meshheading:7974803-Tumor Necrosis Factor-alpha,
pubmed-meshheading:7974803-Umbilical Veins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor alpha and interferon-gamma.
|
pubmed:affiliation |
Department of Immunology, University College and Middlesex School of Medicine, London, U.K.
|
pubmed:publicationType |
Journal Article
|